Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal

A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00781560

Acronym

CRE NIS

Enrollment

2575

Registered

2008-10-29

Start date

2008-10-31

Completion date

2009-07-31

Last updated

2009-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Keywords

Hyperlipidemia, Chinese National Adult Lipid Treatment Guideline (2007), Crestor®

Brief summary

This study is designed to survey the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists; To survey the control rate of the patients with dyslipidemia in real world; and to evaluate the percentage of hyperlipidemia patients who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) following 8-week treatment by Crestor® 5mg or 10mg

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosed as dyslipidemia by doctors * Having lipids test and record within one months * Diagnosed as hypercholesterolemia or mixed dyslipidaemias and has been prescribed Crestor® 5mg or 10mg

Exclusion criteria

* Unable or unwilling to provide the Inform Consent

Design outcomes

Primary

Measure	Time frame
the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists	1 time
the control rate of patients reaching target LDL-C level	8 weeks

Secondary

Measure	Time frame
the percent change from baselines in TC, TG, HDL-C	8 weeks
the percentage of hyperlipidemia patients in different risk categories who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007)	8 weeks

Countries

China

Outcome results